COVID vaccine makers brace for a variant worse than Delta
Companies are updating vaccines and testing them on people to prepare for whatever comes next in the pandemic.
Companies are updating vaccines and testing them on people to prepare for whatever comes next in the pandemic.
Nature Medicine – Causal machine learning methods could be used to predict treatment outcomes for subgroups and even individual patients; this Perspective outlines the potential…
Nature Reviews Immunology – Immune cell engagers — antibody-based molecules engineered to direct immune effector cells to recognize and kill cancer cells — represent a…
Nature – Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off them.
Nature Communications – Lower respiratory tract disease is a common complication after allogeneic hematopoietic cell transplant (HCT), but underlying reasons remain unclear. Here the authors…
Nature Medicine – Recent developments in bioengineering and organic chemistry have enabled targeting of the previously ‘undruggable’ KRAS; this review summarizes the successes,…
Nature Communications – Trait correlations impact evolvability as selection on one trait can influence others. Here, the authors examine trait correlation in two proteins, a…
Nature Communications – Grasses share a whole-genome duplication called rho, but the adaptive implications are unclear. Here, the authors conduct phylogenomic and phylotranscriptomic analyses of…
Nature Communications – Prompt physiological reactivation after rainfall pulses may be key for microbial survival in arid ecosystems. Here, the authors use stable isotope tracers,…
Nature Metabolism – A new methodology uses intravital time-gated mid-infrared optoacoustic signals for accurate non-invasive measurements of glucose concentrations in blood-rich volumes of the skin.
Nature Reviews Endocrinology – This article reviews advances in incretin-based pharmacotherapy, including the latest glucagon-like peptide 1 (GLP1) receptor agonists (GLP1RAs), ‘GLP1…